help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Regnis, J. A.
Right arrow Articles by Bye, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Regnis, J. A.
Right arrow Articles by Bye, P. T.

Am. J. Respir. Crit. Care Med., Vol 150, No. 1, 07 1994, 66-71.

Mucociliary clearance in patients with cystic fibrosis and in normal subjects

JA Regnis, M Robinson, DL Bailey, P Cook, P Hooper, HK Chan, I Gonda, G Bautovich and PT Bye
Department of Respiratory and Nuclear Medicine, Royal Prince Alfred Hospital, Sydney, Australia.

The aim of this study was to examine baseline mucociliary clearance (MCC) in patients with cystic fibrosis (n = 30; mean +/- SEM age, 23 +/- 1 yr; FEV1, 68 +/- 5% pred; range, 14 to 126%) and a group of normal subjects (n = 12; mean age, 27 +/- 1 yr) after an aerosol deposition of 99mTc-sulphur colloid (mass median diameter, 4.8 microns; geometric standard deviation, 1.6). Dynamic geometric mean images were formed from gamma camera data, and the percent clearance of activity after 60 min (%C60) was calculated for the whole right lung. Initial deposition of the aerosol was determined in terms of the penetration index, the ratio of peripheral to central activity. For normal subjects, an increase in mean inspiratory flow rate (MIFR) (49 +/- 5 versus 21 +/- 3 L/min, p < 0.05) resulted in an increase in whole right lung MCC (%C60, 31 +/- 4 versus 18 +/- 2%; p < 0.05). When aerosol delivery was controlled (MIFR, 34 +/- 5 versus 36 +/- 5 L/min), there was excellent reproducibility between studies (whole lung %C60, 34 +/- 8 versus 31 +/- 7; NS). The measurement of MCC was highly reproducible in six patients studied on four occasions with a mean coefficient of variation of 3.3 +/- 1%. A breathing pattern to accentuate central deposition was utilized in the patient studies (MIFR, 49 +/- 4 L/min).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Tarran, B. Button, M. Picher, A. M. Paradiso, C. M. Ribeiro, E. R. Lazarowski, L. Zhang, P. L. Collins, R. J. Pickles, J. J. Fredberg, et al.
Normal and Cystic Fibrosis Airway Surface Liquid Homeostasis: THE EFFECTS OF PHASIC SHEAR STRESS AND VIRAL INFECTIONS
J. Biol. Chem., October 21, 2005; 280(42): 35751 - 35759.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. McShane, J.C. Davies, T. Wodehouse, A. Bush, D. Geddes, and E.W.F.W. Alton
Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect
Eur. Respir. J., July 1, 2004; 24(1): 95 - 100.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. R. Grubb, J. H. Jones, and R. C. Boucher
Mucociliary transport determined by in vivo microdialysis in the airways of normal and CF mice
Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L588 - L595.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R.C. Boucher
New concepts of the pathogenesis of cystic fibrosis lung disease
Eur. Respir. J., January 1, 2004; 23(1): 146 - 158.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
J. J. Wine and N. S. Joo
Submucosal Glands and Airway Defense
Proceedings of the ATS, January 1, 2004; 1(1): 47 - 53.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A E Holland, L Denehy, G Ntoumenopoulos, M T Naughton, and J W Wilson
Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis
Thorax, October 1, 2003; 58(10): 880 - 884.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
G M Nixon, D S Armstrong, R Carzino, J B Carlin, A Olinsky, C F Robertson, and K Grimwood
Early airway infection, inflammation, and lung function in cystic fibrosis
Arch. Dis. Child., October 1, 2002; 87(4): 306 - 311.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. P. Seiler, P. Luner, T. O. Moninger, P. H. Karp, S. Keshavjee, and J. Zabner
Thixotropic Solutions Enhance Viral-Mediated Gene Transfer to Airway Epithelia
Am. J. Respir. Cell Mol. Biol., August 1, 2002; 27(2): 133 - 140.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. T. Ballard, L. Trout, A. Mehta, and S. K. Inglis
Liquid secretion inhibitors reduce mucociliary transport in glandular airways
Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L329 - L335.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
V. De Rose
Mechanisms and markers of airway inflammation in cystic fibrosis
Eur. Respir. J., February 1, 2002; 19(2): 333 - 340.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. Crameri and K. Blaser
Allergy and immunity to fungal infections and colonization
Eur. Respir. J., January 1, 2002; 19(1): 151 - 157.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. J. Bridges, B. B. Newton, J. M. Pilewski, D. C. Devor, C. T. Poll, and R. L. Hall
Na+ transport in normal and CF human bronchial epithelial cells is inhibited by BAY 39-9437
Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L16 - L23.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. L. Laube, R. Jashnani, R. N. Dalby, and P. L. Zeitlin
Targeting Aerosol Deposition in Patients With Cystic Fibrosis : Effects of Alterations in Particle Size and Inspiratory Flow Rate
Chest, October 1, 2000; 118(4): 1069 - 1076.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Y. C. Wong, L. M. Guerdoud, A. Cantin, and D. P. Speert
Glucose Stimulates Phagocytosis of Unopsonized Pseudomonas aeruginosa by Cultivated Human Alveolar Macrophages
Infect. Immun., January 1, 1999; 67(1): 16 - 21.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. M. PILEWSKI and R. A. FRIZZELL
Role of CFTR in Airway Disease
Physiol Rev, January 1, 1999; 79(1): 215 - 255.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D. J Davidson and D. J Porteous
Genetics and pulmonary medicine bullet  1: The genetics of cystic fibrosis lung disease
Thorax, May 1, 1998; 53(5): 389 - 397.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. GOSSELIN, M. M. STEVENSON, E. A. COWLEY, U. GRIESENBACH, D. H. EIDELMAN, M. BOULE, M.-F. TAM, G. KENT, E. SKAMENE, L.-C. TSUI, et al.
Impaired Ability of Cftr Knockout Mice to Control Lung Infection with Pseudomonas aeruginosa
Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1253 - 1262.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. KING, B. DASGUPTA, R. P. TOMKIEWICZ, and N. E. BROWN
Rheology of Cystic Fibrosis Sputum after in vitro Treatment with Hypertonic Saline Alone and in Combination with Recombinant Human Deoxyribonuclease I
Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 173 - 177.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1994 American Thoracic Society
  Solid Organ Transplant for the Intensivist 2008